78
Views
46
CrossRef citations to date
0
Altmetric
Article

Protein thiol oxidation and lipid peroxidation in patients with uraemia

, &
Pages 599-604 | Received 22 Jan 2004, Accepted 28 Apr 2004, Published online: 08 Jul 2009

References

  • Ichikawa I, Kiyama S, Yoshioka T. Renal antioxidant enzymes: their regulation and func-tion. Kidney Int 1994; 45: 1–9.
  • Witko-Sarsat V, Friedlander M, Capeillere Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304–13.
  • Halliwell B. The role of oxygen radicals in human diseases, with particular reference to the vascular system. Haemostasis 1993; 23 Suppl 1: 118–26.
  • Hagg-Weber M, Horl WH. Dysfunction of poly-morphonuclear leukocytes in uremia. Semin Nephrol 1996; 16: 192–201.
  • Rosenkranz AR, Temple E, Traindl O, Heinzl H, Zlabinger GJ. Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membranes. Clin Exp Immunol 1994; 98: 300–5.
  • Sutherland WHF, Walker RJ, Ball MJ, Stapley SA, Robertson MC. Oxidation of low density lipoproteins from patients with renal failure or renal transplantations. Kidney Int 1995; 48: 227— 36.
  • Daschner M, Lenhartz H, Botticher D, Schaefer F, Wollschlager M, Mehls O, Leichsenring M. Influence of dialysis on plasma lipid peroxidation products and antioxidants levels. Kidney Int 1996; 50: 1268–72.
  • Toborek M, Wasik T, Drozdz M, Klin M, Magner-Wrobel K, Kopieczna-Grzebieniak E. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism 1992; 41: 1229–32.
  • Epperlein MM, Nourooz-Zadeh J, Jayasena SD, Hothersall JS, Noronha-Dutra A, Nield GH. Nature and biological significance of free radicals generated during bicarbonate hemodialysis. J Am Soc Nephrol 1998; 9: 457–63.
  • Lean MJ, Davies TJ, Fuller K, Jagger JC, Kirstein B, Partington AG, Urry LZ, Chambers T. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 2003; 112: 915— 23.
  • Gutteridge JMC. Aspects to consider when detecting and measuring lipid peroxidation. Free Radic Res Commun 1986; 1: 173–84.
  • Gutteridge JMC, Quinlan GJ. Malondialdehyde formation from lipid peroxides in the thiobarbi-turic acid test: the role of lipid radicals, iron salts and metal chelators. J Appl Biochem 1983; 5: 293–9.
  • Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70–7.
  • Hu ML. Measurement of protein thiol groups and glutathione in plasma. In: Parker L, editor. Methods in enzymology. Vol. 233. California: Academic Press; 1994. p. 380–5
  • Hu ML, Louie S, Cross CE, Motchnik P, Halliwell B. Antioxidant protection against hypo-chlorous acid in human plasma. J Lab Clin Med 1993; 121: 257–62.
  • Nourooz-Zadeh J. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. In: Parker L, editor. Methods in enzymology. Vol. 300. California: Academic Press; 1999. p. 58–62.
  • Nourooz-ZadehJ,Tajaddini-SarmadiJ,McCarthy S, Betteridge DJ, Wolff SP. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 1995; 44: 1054–8.
  • Luciak M, Trznadel K. Free oxygen species metabolism during hemodialysis with different membranes. Nephrol Dial Transplant 1991; 6: 66— 70.
  • Dasgupta A, Hussain S, Ahmad S. Increased lipid peroxidation in patients on maintenance hemo-dialysis. Nephron 1992; 60: 56–9.
  • Banni S, Lucchi L, Baraldi A, Botti B, Cappeli G, Corongiu F, Dessi MA, Tomasi A, Lusvarghi E. No direct evidence of increased lipid peroxidation in hemodialysis patients. Nephron 1996; 72: 177–83.
  • Hirayama A, Nagase S, Gotoh M, Takemura K, Tomida C, Ueda A, Aoyagi K, Terao J, Koyama A. Hemodialysis does not influence the peroxida-tive state already present in uremia. Nephron 2000; 86: 436–40.
  • Schettler V, Wieland E, Verwiebe R, Schuff-Werner P, Scheler F, Oellerich M. Plasma lipids are not oxidized during hemodialysis. Nephron 1994; 67: 42–7.
  • Gutteridge JMN, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. TIBS 1990; 15: 129–35.
  • Winterbourn CC, Monteiro HP, Galilee CF. Ferritin-dependent lipid peroxidation by stimu-lated neutrophils: inhibition by myeloperoxidase-derived hypochlorous acid but not by endogenous lactoferrin. Biochem Biophys Acta 1990; 1055: 179— 85.
  • Himmelfarb J, McMonagle E, McMenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 2000; 58: 2571–8.
  • Galle J, Seibold S. Has the time come to use antioxidant therapy in uraemic pateints? Nephrol Dial Transplant 2003; 18: 1452— 5.
  • Ha TK, Sattar N, Talwar D, Cooney J, Simpson K, O'Reilly DS, Lean ME. Abnormal antioxidant vitamin and carotenoid status in chronic renal failure. Q J Med 1996; 89: 765–9.
  • Miyata T, Saito A, Kurokawa K, Strihou C. Advanced glycation and lipoxidation end pro-ducts: reactive carbonyl compounds-related urae-mic toxicity. Nephrol Dial Transplant 2001; 16 Suppl. 4: 8–11.
  • Droge W. Free radicals in physiological control of cell function. Physiol Rev 2002; 82: 47–95.
  • Haddad JJ. Antioxidant and prooxidant mechan-isms in the regulation of redox(y)-sensitive tran-scription factors. Cell Signal 2002; 14: 879–97.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.